533 related articles for article (PubMed ID: 2547410)
21. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
22. The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters.
Kuhl H; Jung-Hoffmann C; Weber J; Boehm BO
Contraception; 1993 Jan; 47(1):55-68. PubMed ID: 8436002
[TBL] [Abstract][Full Text] [Related]
23. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
25. Carbohydrate metabolism of Indian women taking steroid contraceptives.
Barsivala VM; Virkar K; Kulkarni RD
Fertil Steril; 1976 Jan; 27(1):87-91. PubMed ID: 1245247
[TBL] [Abstract][Full Text] [Related]
26. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
28. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
29. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
Croxatto HB; Diaz S; Robertson DN; Pavez M
Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139
[TBL] [Abstract][Full Text] [Related]
30. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
Thijssen JH
Ann N Y Acad Sci; 1988; 538():280-6. PubMed ID: 3056190
[TBL] [Abstract][Full Text] [Related]
31. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
32. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
33. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
[TBL] [Abstract][Full Text] [Related]
34. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
Piltonen T; Puurunen J; Hedberg P; Ruokonen A; Mutt SJ; Herzig KH; Nissinen A; Morin-Papunen L; Tapanainen JS
Hum Reprod; 2012 Oct; 27(10):3046-56. PubMed ID: 22811306
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
36. Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively.
Toth EL; Ryan EA
Contraception; 1988 Jun; 37(6):549-54. PubMed ID: 3293908
[TBL] [Abstract][Full Text] [Related]
37. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
[TBL] [Abstract][Full Text] [Related]
39. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
Horwitt MK; Harvey CC; Dahm CH
Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
[TBL] [Abstract][Full Text] [Related]
40. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
